Prognos Health

MAY 31, 2023

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth. There was a special all-day session dedicated to this topic on Sunday, with a scattering of sessions throughout the week that touched on Quality.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Healthcare 52

Prognos Health

MAY 31, 2023

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth. There was a special all-day session dedicated to this topic on Sunday, with a scattering of sessions throughout the week that touched on Quality.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Healthcare 52

Copyright Clearance Center

APRIL 4, 2023

Where it comes into play To eliminate the noise and provide relevant search results, information solutions must go beyond simple keyword matching and to use search engines and algorithms that link concepts, topics, and associations to form a deeper understanding of a user’s intent.

Engineering 98

Engineering Government Safety FDA 98

Pharmaceutical Technology

DECEMBER 5, 2022

According to the deal, Incyte is entitled to receive an upfront payment from CMS, which will also make further potential payments on meeting development, regulatory and commercial milestones. Ruxolitinib cream is the first topical inhibitor of JAK to obtain approval in the US.

Food and Drug Administration 52

Food and Drug Administration Healthcare Provider Food Patients 52

PM360

APRIL 22, 2024

Clinical-Medical-Commercial Collaboration Within the intricate web that is the healthcare ecosystem, stakeholders perceive pharmaceutical companies as singular entities, irrespective of internal divisions between Medical Affairs, clinical and commercial teams.

Medical 52

Medical Healthcare Healthcare Education 52

Pharmaceutical Technology

MARCH 3, 2023

With over 18 years of experience, Alexander Dragitsch is a commercial customer service contract manufacturing (CSCM) manager at Baxter’s Halle/Westfalen facility in Germany. Alex and his team have the significant responsibility of managing various commercial programs for more than 40 marketed products.

Specialization 52

Specialization Management Manufacturing Biopharma 52

Pharmaceutical Technology

MAY 17, 2023

AGC Biologics has introduced the BravoAAV and ProntoLVV viral vector platforms that offer quick clinical and commercial production and release of good manufacturing practices (GMP). Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Manufacturing 52

Manufacturing Networking Patients Leads 52

Healthcare Success

AUGUST 14, 2023

Here’s how to do it right Brainstorm possible search topics and questions Begin with a list of queries you think your audience would search for. Avoid keyword cannibalization Google wants you to have one page per topic. Your website should have pages for all your products, services, treatments, etc. Facebook, Healthcare Success, etc.)

Engineering 52

Engineering Healthcare Healthcare Competition 52

Pharmaceutical Technology

JUNE 9, 2023

The US Food and Drug Administration (FDA) has granted approval to commence commercial production at Bristol Myers Squibb’s new advanced cell therapy manufacturing facility in Devens, Massachusetts. The site has been involved in the development, manufacture and testing of clinical and commercial medicines.

Food and Drug Administration 52

Food and Drug Administration FDA Manufacturing Engineering 52

PharmaTech

SEPTEMBER 19, 2022

fast-growing, end-to-end CDMO service provider in Nashville, TN that offers development, testing, and fill/finish cGMP manufacturing for sterile injectable and topical products – all under one roof. Discovery the industry's best kept secret.a

Manufacturing 40

Manufacturing 40

PharmaTech

AUGUST 31, 2022

fast-growing, end-to-end CDMO service provider in Nashville, TN that offers development, testing and fill/finish cGMP manufacturing for sterile injectable and topical products. Here what over 300 decision makers had to say about post-Covid trends - and also the discovery of the industry's best kept secret.a

Manufacturing 40

Manufacturing Marketing 40

Pharmaceutical Technology

OCTOBER 25, 2022

To aid Taysha in using the gene therapy clinical and commercial capabilities of Astellas for TSHA-120 and TSHA-102 development, Astellas will receive a board observer seat on Taysha’s directors’ board. Topic sponsors are not involved in the creation of editorial content.

Biopharma 105

Biopharma Pharmaceutical Manufacturing Patients 105

Pharmaceutical Technology

NOVEMBER 16, 2022

A custom-made viral vector and cell therapy centre of excellence, ElevateBio BaseCamp has an end-to-end process development and existing Good Manufacturing Practice (cGMP) production expertise for research, clinical and commercial cell and gene therapies and regenerative treatments.

Engineering 98

Engineering Manufacturing Pharmaceutical Patients 98

pharmaphorum

OCTOBER 28, 2022

Nina Pinwill BSc (Hons) MSc DIC, is the Head of Commercial Operations at NHS England and NHS Improvement. Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England. She is an SME in market access, rare disease and biosimilars.

Medicine 112

Medicine Management Marketing Leads 112

Pharmaceutical Technology

JANUARY 5, 2023

Capsida Biotherapeutics CEO Peter Anastasiou said: “Prevail’s expertise in neuroscience, gene therapy R&D, and access to Lilly’s world-class commercialization capabilities complements Capsida’s fully integrated approach, including our next-generation AAV engineering platform. Free Whitepaper.

Engineering 95

Engineering Leads Pharmaceutical Marketing 95

Clarivate

JANUARY 23, 2024

R&D productivity fell in 2022, but late-phase cancellations are also trending down The rise and fall of R&D productivity across the global biopharmaceutical industry is a well-documented and much discussed topic, with industry commentators quantifying productivity in many ways (e.g., Learn more about purchasing it here.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

Pharmaceutical Technology

JUNE 12, 2023

Patients with erectile dysfunction (ED) will now be able to access a topical treatment without the need for a prescription after the US Food and Drug Administration (FDA) greenlit Futura Medical’s Eroxon. The addition of a topical gel to pharmacy shelves expands treatment options available to those with ED.

Food and Drug Administration 52

Food and Drug Administration FDA Prescription Food 52

Pharmaceutical Technology

MAY 24, 2023

The BGTC aims to expedite the development, manufacture and delivery of customised or “bespoke” gene therapies to treat rare diseases, including some which are too rare to be of commercial interest. Topic sponsors are not involved in the creation of editorial content.

Food and Drug Administration 96

Food and Drug Administration Manufacturing FDA Food 96

Impetus Digital

OCTOBER 18, 2022

Among many other topics, they will explore digital therapeutics, how DarioHealth is utilizing AI and behavioral science to personalize each user’s health journey, and how this approach can help improve diversity & inclusion. If you would like to pass along this invite to any of your colleagues, feel free to send them this link: [link].

Professional Services 52

Professional Services Management Healthcare Provider Healthcare 52

Pharma Marketing Network

APRIL 5, 2023

The event included a focus on Medical Affairs, as a reflection of industry moving away from a ‘church and state’ approach to medical and commercial. We also saw the addition of a track focused on Cell and Gene Therapy, as Pharma ventures into the commercialization of therapeutics. A more ‘systematized’ approach to insights.

Pharma 52

Pharma Marketing Competition Networking 52

Pharmaceutical Technology

AUGUST 28, 2022

Additionally, it expected firms such as Pfizer and BioNTech to respect its intellectual property rights and considered granting them a commercially reasonable licence, if they sought one for other markets. Topic sponsors are not involved in the creation of editorial content.

Food and Drug Administration 98

Food and Drug Administration Food Marketing Pharmaceutical 98

Pharmaceutical Technology

MARCH 29, 2023

The companies will co-fund research and development for all products and split the future commercial expenses and profits equally. Topic sponsors are not involved in the creation of editorial content. Sonoma will also be eligible to receive a development milestone payment of $45m.

Leads 98

Leads Engineering Pharmaceutical Patients 98

pharmaphorum

AUGUST 22, 2022

Among the infinite symposia, webinars, and white papers on this topic,?“KOL KOL identification is the process of identifying those individuals with high levels of expertise and influence in a given therapeutic area; in the context of building your medical and commercial strategy.? Robert Hollands. e: robert.hollands@vmlyr.com.

Media 52

Media Networking Medical Management 52

Pharmaceutical Technology

MAY 4, 2023

Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Manufacturing 102

Manufacturing Patients Medicine Leads 102

pharmaphorum

AUGUST 31, 2022

Futura Medical’s development of a topical treatment for erectile dysfunction (ED) is approaching the finish line in the US, as the UK biotech reports confirmatory phase 3 data ahead of an FDA filing later this month. ” The post Futura eyes FDA filing as topical ED drug passes phase 3 test appeared first on.

FDA 52

FDA Side effects Prescription Medical 52

Impetus Digital

JUNE 29, 2022

Together, they will explore topics related to EUDAMED–the European Databank for Medical Devices–including the key pain points and concerns MedTech companies frequently encounter when working on their submissions. If you would like to pass along this invite to any of your colleagues, feel free to send them this link: [link].

Professional Services 52

Professional Services Healthcare Provider Healthcare Healthcare 52

Impetus Digital

OCTOBER 5, 2022

Natalie Yeadon Co-Founder & CEO Natalie worked in the pharmaceutical industry for over 18 years in a variety of sales, marketing, and early brand commercialization management roles both in Canada and in the US, in several different therapeutic areas. He has also led three companies from start to successful exit. About Impetus Digital.

Transportation 52

Transportation Professional Services Healthcare Healthcare 52

Pharmaceutical Technology

FEBRUARY 13, 2023

This trial assessed Cibinqo 100mg and 200mg doses against placebo in moderate-to-severe AD adolescents aged 12 to less than 18 years who were on background treatment with topical medications.

Food and Drug Administration 59

Food and Drug Administration FDA Food Medicine 59

Pharmaceutical Technology

AUGUST 17, 2022

It will also have the potential to scale to Phase III clinical development and commercial manufacturing. RoosterBio CEO Tim Kelly said: “AGC Biologics has an outstanding track record of success in the manufacture of clinical and commercial advanced therapies and an ever-expanding global network to meet the needs of our customers.

Manufacturing 52

Manufacturing Networking Media Engineering 52

Impetus Digital

AUGUST 12, 2022

They will also dive into topics related to patient-centricity and digital technologies in Pharma, including how these can be used to support HCPs and patients during this challenging time. Sign up now! Register for this free webinar. Book a Consultative Demo.

Medical 52

Medical Professional Services Medical science Healthcare Provider 52

Pharmaceutical Technology

FEBRUARY 23, 2023

To support the mRNA initiatives, RVAC Medicines will continue to partner with GenScript ProBio for the clinical-stage development and commercial stage of its candidates. Topic sponsors are not involved in the creation of editorial content. RVAC Medicines CEO Dr Sean Fu said: “We are excited to work closely with GenScript ProBio.

Manufacturing 115

Manufacturing Medicine Consulting Pharmaceutical 115

pharmaphorum

NOVEMBER 3, 2022

With pharmaphorum once more in attendance, expect coverage of an ever wide and ranging spectrum of topics, all united by the shared goal of seeking sustainable change for Britain, whilst bearing in mind her role upon the global stage at this critical juncture in history.

Government 73

Government Pharma 73

Cesare Ferrari

JULY 18, 2022

This post explores this hot topic and provides practical advice to increase integration between marketing and sales. In this post , I suggested some key factors to consider when deciding between the 2 main commercial approaches: direct or indirect.

Sales 52

Sales Marketing 52

Pharmaceutical Technology

JANUARY 27, 2023

After the NHS Commercial Medicines Directorate signed a confidential commercial deal with the company, axicabtagene ciloleucel will be commissioned routinely to patients in England. Topic sponsors are not involved in the creation of editorial content. The new CAR-T therapy will be given as a one-off intravenous infusion.

Medicine 59

Medicine Patients Pharmaceutical Leads 59

Pharmaceutical Technology

SEPTEMBER 29, 2022

Scribe is also entitled to receive potential payments worth over $1bn on meeting development and commercial milestones. Topic sponsors are not involved in the creation of editorial content. According to the deal, Sanofi will make an upfront payment of $25m to Scribe.

Engineering 52

Engineering Pharmaceutical Sales 52

Clarivate

NOVEMBER 28, 2023

This dynamic view of the research landscape is invaluable in providing knowledge and foresight to policymakers and administrators in governmental, academic, and commercial settings—as well as to anyone with an interest in the latest areas of concentration and activity in science.

Specialization 59

Specialization Medicine Leads Government 59

Pharmaceutical Technology

AUGUST 30, 2022

Moderna chief commercial officer Arpa Garay said: “We are delighted to receive authorization from Swissmedic for our next-generation bivalent vaccine, mRNA-1273.214. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Government 52

Government Safety Pharmaceutical Medicine 52